Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2015) | Total Docs. (3years) | Total Refs. (2015) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2015) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Particle and Fibre Toxicology | journal | 3.074 Q1 | 119 | 34 | 186 | 2019 | 1709 | 180 | 9.38 | 59.38 |  |
| 2 | Theranostics | journal | 2.586 Q1 | 158 | 109 | 297 | 6584 | 2794 | 277 | 9.33 | 60.40 |  |
| 3 | PLoS Neglected Tropical Diseases | journal | 2.444 Q1 | 163 | 823 | 1914 | 37853 | 9006 | 1898 | 4.38 | 45.99 |  |
| 4 | Molecular Therapy - Nucleic Acids | journal | 2.308 Q1 | 95 | 53 | 214 | 2992 | 1147 | 198 | 5.48 | 56.45 | |
| 5 | Journal for ImmunoTherapy of Cancer | journal | 1.929 Q1 | 117 | 83 | 63 | 2067 | 318 | 60 | 5.05 | 24.90 | |
| 6 | Nanotechnology, Science and Applications | journal | 1.888 Q1 | 35 | 6 | 14 | 413 | 128 | 14 | 7.17 | 68.83 |  |
| 7 | Frontiers in Pharmacology | journal | 1.886 Q1 | 154 | 303 | 628 | 22107 | 2862 | 592 | 4.48 | 72.96 |  |
| 8 | Emerging Microbes and Infections | journal | 1.785 Q1 | 94 | 49 | 114 | 1838 | 433 | 105 | 4.20 | 37.51 | |
| 9 | Expert Review of Vaccines | journal | 1.772 Q1 | 105 | 107 | 459 | 9145 | 1608 | 408 | 3.46 | 85.47 | |
| 10 | International Journal of Neuropsychopharmacology | journal | 1.764 Q1 | 125 | 177 | 548 | 9768 | 2285 | 533 | 4.05 | 55.19 | |
| 11 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 1.688 Q1 | 47 | 27 | 91 | 1288 | 394 | 91 | 4.25 | 47.70 |  |
| 12 | Protein and Cell | journal | 1.659 Q1 | 94 | 111 | 320 | 4793 | 1005 | 290 | 3.36 | 43.18 | |
| 13 | Human Genomics | journal | 1.598 Q1 | 68 | 31 | 71 | 1471 | 250 | 68 | 3.64 | 47.45 | |
| 14 | CNS Neuroscience and Therapeutics | journal | 1.553 Q1 | 91 | 125 | 464 | 6311 | 1557 | 348 | 3.27 | 50.49 | |
| 15 | Diabetes, Metabolic Syndrome and Obesity | journal | 1.463 Q1 | 64 | 57 | 153 | 2744 | 697 | 149 | 4.77 | 48.14 | |
| 16 | International Journal of Nanomedicine | journal | 1.323 Q1 | 179 | 587 | 1433 | 28790 | 7677 | 1406 | 4.69 | 49.05 | |
| 17 | Altex | journal | 1.320 Q1 | 64 | 36 | 127 | 1912 | 477 | 103 | 3.80 | 53.11 |  |
| 18 | Cancer Biology and Therapy | journal | 1.313 Q1 | 130 | 208 | 520 | 8550 | 1641 | 488 | 2.95 | 41.11 | |
| 19 | International Journal of Pharmaceutics | journal | 1.298 Q1 | 258 | 911 | 2282 | 36535 | 10490 | 2245 | 4.53 | 40.10 | |
| 20 | Perspectives in Medicinal Chemistry | journal | 1.285 Q1 | 17 | 3 | 5 | 193 | 29 | 5 | 5.80 | 64.33 | |
| 21 | Pharmaceuticals | journal | 1.273 Q1 | 87 | 44 | 206 | 3690 | 832 | 203 | 5.00 | 83.86 | |
| 22 | Cancer Chemotherapy and Pharmacology | journal | 1.266 Q1 | 122 | 280 | 889 | 8763 | 2864 | 877 | 3.26 | 31.30 | |
| 23 | Infection and Drug Resistance | journal | 1.263 Q1 | 65 | 39 | 82 | 2276 | 321 | 82 | 4.32 | 58.36 | |
| 24 | Cardiovascular Therapeutics | journal | 1.259 Q1 | 54 | 50 | 192 | 1995 | 578 | 181 | 2.50 | 39.90 | |
| 25 | Current Pharmaceutical Design | journal | 1.242 Q1 | 183 | 614 | 1877 | 67431 | 6187 | 1727 | 3.19 | 109.82 |  |
| 26 | Journal of Nanobiotechnology | journal | 1.219 Q1 | 109 | 89 | 155 | 4161 | 876 | 154 | 4.85 | 46.75 | |
| 27 | Pharmacogenomics and Personalized Medicine | journal | 1.195 Q1 | 37 | 15 | 63 | 858 | 275 | 63 | 4.46 | 57.20 | |
| 28 | European Journal of Pharmaceutical Sciences | journal | 1.167 Q1 | 163 | 258 | 765 | 11168 | 3396 | 753 | 4.40 | 43.29 | |
| 29 | PharmacoEconomics | journal | 1.143 Q1 | 118 | 105 | 294 | 5466 | 733 | 245 | 2.44 | 52.06 | |
| 30 | Therapeutic Advances in Neurological Disorders | journal | 1.113 Q2 | 68 | 30 | 84 | 1534 | 329 | 81 | 3.50 | 51.13 | |
| 31 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 1.110 Q2 | 57 | 60 | 177 | 2823 | 515 | 172 | 3.10 | 47.05 | |
| 32 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 1.095 Q1 | 92 | 139 | 403 | 5786 | 1330 | 402 | 3.29 | 41.63 | |
| 33 | Life Sciences | journal | 1.066 Q1 | 191 | 371 | 1025 | 19955 | 3098 | 1015 | 3.06 | 53.79 | |
| 34 | Core Evidence (discontinued) | journal | 1.051 Q2 | 29 | 8 | 32 | 471 | 130 | 31 | 4.30 | 58.88 | |
| 35 | Pharmacognosy Reviews (discontinued) | journal | 1.019 Q1 | 68 | 24 | 65 | 1200 | 259 | 65 | 3.73 | 50.00 |  |
| 36 | PPAR Research | journal | 0.992 Q1 | 59 | 23 | 151 | 1800 | 379 | 144 | 2.94 | 78.26 | |
| 37 | Drug Design, Development and Therapy | journal | 0.982 Q1 | 94 | 527 | 424 | 23818 | 1498 | 422 | 3.44 | 45.20 | |
| 38 | Human Vaccines and Immunotherapeutics | journal | 0.973 Q2 | 93 | 381 | 1253 | 16584 | 2510 | 975 | 1.93 | 43.53 | |
| 39 | Journal of Medical Toxicology | journal | 0.973 Q2 | 58 | 80 | 222 | 1733 | 644 | 183 | 2.16 | 21.66 | |
| 40 | Toxins | journal | 0.971 Q2 | 116 | 342 | 455 | 20394 | 1960 | 447 | 4.05 | 59.63 | |
| 41 | Journal of Pharmacological Sciences | journal | 0.948 Q2 | 101 | 136 | 428 | 4858 | 1068 | 427 | 2.46 | 35.72 |  |
| 42 | Journal of Physiology and Pharmacology | journal | 0.936 Q2 | 89 | 90 | 263 | 5070 | 769 | 263 | 3.05 | 56.33 |  |
| 43 | Vaccines | journal | 0.882 Q2 | 85 | 51 | 44 | 4651 | 82 | 42 | 1.86 | 91.20 | |
| 44 | Pharmacological Reports | journal | 0.864 Q2 | 98 | 183 | 499 | 8844 | 1348 | 497 | 2.53 | 48.33 | |
| 45 | BMC pharmacology & toxicology | journal | 0.853 Q2 | 43 | 41 | 160 | 1456 | 393 | 154 | 2.57 | 35.51 | |
| 46 | Drug Target Insights | journal | 0.845 Q1 | 16 | 5 | 17 | 225 | 52 | 17 | 3.23 | 45.00 |  |
| 47 | Biomedicine and Pharmacotherapy | journal | 0.810 Q2 | 149 | 289 | 375 | 10282 | 982 | 372 | 2.64 | 35.58 |  |
| 48 | Drug Metabolism and Pharmacokinetics | journal | 0.805 Q1 | 75 | 65 | 237 | 2463 | 584 | 218 | 1.89 | 37.89 | |
| 49 | Biomarker Insights | journal | 0.800 Q2 | 40 | 68 | 45 | 5487 | 111 | 44 | 1.83 | 80.69 | |
| 50 | Dose-Response | journal | 0.781 Q2 | 48 | 45 | 126 | 2842 | 284 | 119 | 2.56 | 63.16 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data